SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-018249
Filing Date
2024-05-24
Accepted
2024-05-24 08:00:10
Documents
16
Period of Report
2024-05-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20240523c_8k.htm   iXBRL 8-K 29220
2 EXHIBIT 99.1 ex_679388.htm EX-99.1 9977
7 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-24-018249.txt   185420

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240523.xsd EX-101.SCH 3409
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240523_def.xml EX-101.DEF 11804
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240523_lab.xml EX-101.LAB 15848
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240523_pre.xml EX-101.PRE 12019
19 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240523c_8k_htm.xml XML 2958
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 24980853
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)